ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
38 announcements with these filters
Indo Borax & Chemicals Ltd has availed funding of ₹225 Crore from a lending institution. The capital will finance its acquisition of equity shares in Kronox Lab Sciences Limited.
Indo Borax & Chemicals reported postal ballot results where shareholders approved borrowing limits up to Rs 400 Crore. One special resolution passed with 98.05% in favour.
Indo Borax reported robust Q1 FY27 results with 31% revenue growth and 59% PAT growth. Management announced a major acquisition of 64.26% stake in Kronox Lab Sciences to diversify into high-purity specialty chemicals.
Indo Borax reported strong Q1FY27 consolidated performance with Revenue up 31% and PAT up 59% YoY. Strategy focuses on high-margin DOT expansion and the acquisition of Kronox Lab Sciences.
Indo Borax & Chemicals Ltd received a credit rating update from India Ratings, placing its bank loan facilities on 'Rating Watch with Negative Implications'.
Indo Borax & Chemicals Ltd. is relocating its corporate office to a new premises in Andheri (East), Mumbai, effective September 15, 2026.
Indo Borax & Chemicals Limited has announced the acquisition of Kronox Lab Sciences Limited for Rs. 103.22 Crore. The cash deal aims to diversify the company's chemical portfolio.
Indo Borax & Chemicals approved the acquisition of a 64.26% stake in Kronox Lab Sciences for ₹246.12 Crore. The transaction triggers a mandatory open offer for another 25.79%.
Indo Borax & Chemicals Limited issued a postal ballot notice seeking shareholder approval to revise the company's borrowing limits.
Indo Borax & Chemicals Ltd has issued a Postal Ballot notice seeking shareholder approval to increase its borrowing limit to ₹400 Crore.
Indo Borax reported a 59% surge in net profit to Rs 16.25 crore for Q1FY27. The company also announced the amalgamation of its wholly-owned subsidiary.
Indo Borax & Chemicals Ltd reported revenue from operations of ₹70.4 Cr (+31.3% YoY) and net profit of ₹16.3 Cr (+59.8% YoY) for Q1 FY27.
Indo Borax & Chemicals has scheduled a board meeting for August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Indo Borax & Chemicals Limited conducted its 45th Annual General Meeting via video conferencing on July 28, 2026, to transact scheduled business and shareholder resolutions.
India Ratings and Research assigned 'IND BBB+/Stable/IND A2+' ratings to Indo Borax & Chemicals Ltd's bank loan facilities worth ₹60 Crore.
The company submitted its quarterly shareholding pattern for the period ending June 30, 2026, pursuant to SEBI Regulation 31(1)(b).
Indo Borax & Chemicals approved the amalgamation of its wholly owned subsidiary, Indoborax Infrastructure Private Limited. The board also approved shifting the company's registered office.
Indo Borax & Chemicals Ltd. intimated the record date for its 45th AGM and dividend payment. Book closure is from July 22 to 28, 2026.
Indo Borax filed its 45th Annual Report for FY 2025-26, highlighting strong performance. It plans to invest Rs. 20 crore in a new 4,000 MTPA Boron Oxide facility.
Indo Borax & Chemicals Ltd announced grant of 1,688,950 employee stock options under ESOP 2026. The options carry Rs.1 face value per share.
Indo Borax & Chemicals Limited transcript for Q4 and FY26. Management reports significant transformation under new ownership by Zenrock Chemicals, achieving record revenue growth with a focus on operational efficiency and boron chemistry expansion.
Indo Borax delivered solid FY26 performance with consolidated revenue of ₹215.45 Cr and PAT of ₹50.27 Cr, following a major 50.80% ownership transition to institutional investors.
Indo Borax & Chemicals submitted its Annual Secretarial Compliance Report for FY26. The report confirms adherence to SEBI regulations with no material non-compliance observations.
Indo Borax & Chemicals issued a typographical correction for its FY26 financial results. No changes were made to the company's financial figures or reported profitability.
Indo Borax & Chemicals recommended a Rs. 10 final dividend and Rs. 30 special dividend per share. Totaling 4000% of face value, record dates are pending.
Indo Borax & Chemicals appointed Shah Kapadia & Associates as Internal Auditors and re-appointed V. B. Modi & Associates as Cost Auditors. Both terms are for twelve months.
Indo Borax & Chemicals Ltd reported revenue from operations of ₹63 Cr (+25.7% YoY) and net profit of ₹14.5 Cr (+42.2% YoY) for Q4 FY26.
Indo Borax reported audited FY26 financial results and recommended a final and special dividend totaling ₹40 per share. The board also reconstituted its NRC committee.
Indo Borax & Chemicals scheduled a board meeting on May 21, 2026. The board will consider audited financial results and potential dividend recommendations.
Zenrock Chemicals Private Limited pledged 24,44,534 shares of Indo Borax & Chemicals Limited as debt security. The transaction involves Catalyst Trusteeship and several special situation funds.